Exagon Inc. has been acquired by Berger-Levrault Ltd.
The private shareholders of Exagon Inc. have sold the company to Berger-Levrault Ltd. for an undisclosed amount.
Exagon Inc. is a Quebec-based software design company that builds software that helps manage financial resources, human resources and investments for schools, corporations and government entities.
Berger Levrault Ltd., a creative and innovative France-based company, is the leading provider of business software in Europe. It has over 40,000 clients and generates revenues upwards of US$100 million annually.
Oaklins' team in Montreal advised the seller in this transaction.
Contacter l'équipe de la transaction
Transactions connexes
Niscon Inc. a été acquise par SGPS ShowRig.
Niscon Inc. a été acquise avec succès par SGPS ShowRig, un fournisseur mondial de solutions de scène, de levage et d’automatisation pour le divertissement en direct. Cette acquisition renforce l’engagement de SGPS ShowRig à repousser les limites de l’innovation dans l’industrie du divertissement. En intégrant la technologie unique de contrôle de mouvement de Niscon à son portefeuille, SGPS ShowRig renforce sa capacité à offrir des solutions de pointe, précises et innovantes.
En apprendre plusFairfest Media has acquired WTE Miami
Fairfest Media, organizer of OTM, the leading travel show in Asia, has acquired WTE Miami, the fastest-growing travel trade show in the USA. The acquisition marks a significant milestone in Fairfest’s global expansion, strengthening its presence in the Americas and beyond by leveraging decades of experience and leadership in Asia and India.
En apprendre plusBanook, backed by Motion Equity, has acquired Fluidda
Banook Group has acquired Fluidda NV, marking a strategic expansion into advanced in-silico trials and respiratory disease modeling. Combining Banook’s expertise in cardiac safety and clinical data services with Fluidda’s AI-driven respiratory analytics creates a powerful, integrated platform. This deal strengthens Banook’s position in the contract research organization (CRO) sector, offering pharmaceutical clients broader, technology-enabled solutions to drive drug development and reduce costs.
En apprendre plus